Fab'entech

Fab'entech

Fab'entech

#Biopharmaceutical company specialized in passive immunotherapy based on specific polyclonal immunoglobulins [F(ab')2] against emerging #infectiousdiseases.
Founded
2009
Raised
$4.1M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$4,128,628
Venture capital (Series A) - 2014
Team Size
10+
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Fab'entech makes some noise.